| Product NDC: | 16590-265 |
| Proprietary Name: | CIMETIDINE |
| Non Proprietary Name: | CIMETIDINE |
| Active Ingredient(s): | 400 mg/1 & nbsp; CIMETIDINE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 16590-265 |
| Labeler Name: | STAT RX USA LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074424 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100526 |
| Package NDC: | 16590-265-56 |
| Package Description: | 56 TABLET, FILM COATED in 1 BOTTLE (16590-265-56) |
| NDC Code | 16590-265-56 |
| Proprietary Name | CIMETIDINE |
| Package Description | 56 TABLET, FILM COATED in 1 BOTTLE (16590-265-56) |
| Product NDC | 16590-265 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CIMETIDINE |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20100526 |
| Marketing Category Name | ANDA |
| Labeler Name | STAT RX USA LLC |
| Substance Name | CIMETIDINE |
| Strength Number | 400 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |